Telehealth provider Teladoc last week accused Amwell of infringing on its patents and demanded that its rival stop offering the products in question — setting the stage for a potential legal dispute between the two most prominent companies in telemedicine.
Trending:
Teladoc accuses Amwell of infringing on its telehealth patents